Login / Signup

Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia.

Ivan O RosasNorbert BräuMichael WatersRonaldo C GoBradley D HunterSanjay BhaganiDaniel SkiestMariam S AzizNichola CooperIvor S DouglasSinisa SavicTaryn YoungsteinLorenzo Del SorboAntonio Cubillo GracianDavid J De La ZerdaAndrew UstianowskiMin BaoSophie DimonacoEmily GrahamBalpreet MatharuHelen SpotswoodLarry TsaiAtul Malhotra
Published in: The New England journal of medicine (2021)
In this randomized trial involving hospitalized patients with severe Covid-19 pneumonia, the use of tocilizumab did not result in significantly better clinical status or lower mortality than placebo at 28 days. (Funded by F. Hoffmann-La Roche and the Department of Health and Human Services; COVACTA ClinicalTrials.gov number, NCT04320615.).
Keyphrases